COMMERCIALISATION
The Rydalmere facility has validated the commercial viability of CathRx’s diagnostic catheters, supporting customer orders and clinical trial units. This low-volume site is globally approved and continues to fulfil small-scale demand while enabling real-world feedback and refinement.





